VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - May 14, 2007) - Pyng Medical Corp. has launched its FAST1(TM) Intraosseous Infusion System into the Asian market. Goodwin Health Care Ltd., one of the leading suppliers of EMS and hospital products in Hong Kong, has placed their first purchase order with Pyng Medical Corp. The introduction of the FAST1(TM) will provide a safer, faster and more reliable vascular access for fluid resuscitation in shock and trauma situations.
"We are thrilled to be doing business on the continent of Asia. Thanks to its lower regulatory hurdles Hong Kong is a logical beachhead for entry in to the rest of China. This confirms for Pyng we made the right decision to retain Larry Kronick, Business Asia Consultants, as our Asia Pacific Region Manager, and we expect more orders to follow soon," said David Christie, President and Chief Executive Officer.
"We are pleased to be working with Pyng Medical Corp and introduce the FAST1(TM) Intraosseous Infusion System to the emergency care sector in Hong Kong. It offers a great opportunity for the local emergency care services when saving lives," said Tony Wong, General Manager of Goodwin Health Care Ltd.
About Pyng Medical Corp.
Pyng Medical Corp. is a world-leader in intraosseous infusion with its proprietary award-winning FAST1(TM) Intraosseous Infusion System. The FAST1(TM) is used extensively by the U.S. Department of Defense and by Emergency Medical Services around the globe.
Safe Harbour Statement: Forward-Looking Statements: This release may contain forward-looking statements based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects", "anticipates", "plans", "intends", "projects", "indicates", and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.
FOR FURTHER INFORMATION PLEASE CONTACT:
Pyng Medical Corp.